This document summarizes the key elements of the BMT (biomedical technologies) innovation ecosystem in Russia, including infrastructure, regulatory environment, educational programs, and partnerships. It discusses the community of BMT cluster residents, business incubators, venture capital funds, and other experts and institutional partners involved. Specific cooperation agreements and plans are outlined between the BMT cluster and government organizations, funds, universities, and other biomedical and pharmaceutical clusters in Russia. Educational programs and practices are described, along with profiles of six projects that received financing approval from the BMT cluster's investment committee.
The University Technology Transfer Centre (UTTC)
is part of the University; it provides students, PhD
candidates, and researchers with comprehensive
support at every stage of innovation development
– from the pre-incubation of ideas, to international
patent protection, company start-ups, and
initiating business contacts.
Spanish National Biobank Network Strategic PlanEuroBioForum
The Spanish National Biobank Network approved a 2010-2013 Strategic Plan to integrate and harmonize hospital biobanks across Spain in order to better support biomedical research. The network was established by the Spanish Ministry of Science and Innovation and Carlos III Health Institute to meet legal requirements, provide added value through integration and public service, and facilitate researchers' access to quality biological samples and data. The Strategic Plan aims to further develop the network's organizational structure and strengthen its role in supporting translational research.
Presentation from the 3rd Joint Meeting of the Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Networks, organised by the European Centre of Disease Prevention and Control - Stockholm, 11-13 February 2015
Creating collaborative systems to address orphan drugs in a sustainable way –...Dutch Orphan Drug Network
Creating collaborative systems to address orphan drugs in a sustainable way. The document discusses several European initiatives aimed at improving access to orphan drugs in a sustainable manner, including:
1. CAVOD (Clinical Added Value of Orphan Drugs) which aims to reduce the gap between marketing authorization and patient access through early dialogue and compiling evidence reports.
2. MOCA (Mechanism of Coordinated Access to Orphan Drugs) which seeks to create a shared mechanism between 15 countries to streamline pricing and reimbursement processes for orphan drugs.
3. The development of national plans for rare diseases in EU member states by 2013 to help coordinate diagnosis, treatment and research across countries.
4. Other
This document provides an overview of the Skolkovo Innovation Center located near Moscow, Russia. It discusses the following key points in 3 sentences or less:
- Skolkovo was established in 2010 as an innovation cluster with important benefits like proximity to Moscow, large land area, tax incentives and strong IP protection.
- By 2013, Skolkovo had its first building, 200 students enrolled, 790 startups (270 in IT) and received $277 million in state grants along with venture funding and agreements with multinational corporations to open R&D centers.
- Skolkovo aims to diversify the Russian economy through innovation and entrepreneurship by integrating Russian science and technology globally and
Presentation Slides of Prof Jong-oh Park on RoboticsAlbert Yefimov
This document discusses the rise of service robots and the director's journey towards miniaturizing robots. It provides statistics on industrial and service robot markets and forecasts. In 3 sentences: The director discusses the growth of service robots since 2000 as compared to industrial robots since 1970, and his work developing increasingly smaller colonoscope, capsule endoscope, and intravascular robots down to the nanometer scale. Charts show the value and forecast of industrial, professional service, and personal service robot markets globally.
The University Technology Transfer Centre (UTTC)
is part of the University; it provides students, PhD
candidates, and researchers with comprehensive
support at every stage of innovation development
– from the pre-incubation of ideas, to international
patent protection, company start-ups, and
initiating business contacts.
Spanish National Biobank Network Strategic PlanEuroBioForum
The Spanish National Biobank Network approved a 2010-2013 Strategic Plan to integrate and harmonize hospital biobanks across Spain in order to better support biomedical research. The network was established by the Spanish Ministry of Science and Innovation and Carlos III Health Institute to meet legal requirements, provide added value through integration and public service, and facilitate researchers' access to quality biological samples and data. The Strategic Plan aims to further develop the network's organizational structure and strengthen its role in supporting translational research.
Presentation from the 3rd Joint Meeting of the Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Networks, organised by the European Centre of Disease Prevention and Control - Stockholm, 11-13 February 2015
Creating collaborative systems to address orphan drugs in a sustainable way –...Dutch Orphan Drug Network
Creating collaborative systems to address orphan drugs in a sustainable way. The document discusses several European initiatives aimed at improving access to orphan drugs in a sustainable manner, including:
1. CAVOD (Clinical Added Value of Orphan Drugs) which aims to reduce the gap between marketing authorization and patient access through early dialogue and compiling evidence reports.
2. MOCA (Mechanism of Coordinated Access to Orphan Drugs) which seeks to create a shared mechanism between 15 countries to streamline pricing and reimbursement processes for orphan drugs.
3. The development of national plans for rare diseases in EU member states by 2013 to help coordinate diagnosis, treatment and research across countries.
4. Other
This document provides an overview of the Skolkovo Innovation Center located near Moscow, Russia. It discusses the following key points in 3 sentences or less:
- Skolkovo was established in 2010 as an innovation cluster with important benefits like proximity to Moscow, large land area, tax incentives and strong IP protection.
- By 2013, Skolkovo had its first building, 200 students enrolled, 790 startups (270 in IT) and received $277 million in state grants along with venture funding and agreements with multinational corporations to open R&D centers.
- Skolkovo aims to diversify the Russian economy through innovation and entrepreneurship by integrating Russian science and technology globally and
Presentation Slides of Prof Jong-oh Park on RoboticsAlbert Yefimov
This document discusses the rise of service robots and the director's journey towards miniaturizing robots. It provides statistics on industrial and service robot markets and forecasts. In 3 sentences: The director discusses the growth of service robots since 2000 as compared to industrial robots since 1970, and his work developing increasingly smaller colonoscope, capsule endoscope, and intravascular robots down to the nanometer scale. Charts show the value and forecast of industrial, professional service, and personal service robot markets globally.
RUbiomed is a community of biotechnology and medical professionals working on the Skolkovo Foundation Biomedicine Cluster platform. Its mission is to contribute to the successful development of Russian science and enterprise in these fields by creating a platform to connect entrepreneurs, experts, investors and government. This will help establish cooperation between science, business and government. The goals are to create conditions for successful communication, ensure access to capital and resources, organize educational programs, and support the formation of a class of qualified experts. Objectives include forming an ecosystem conducive to innovation, establishing shared research centers, supporting members' projects, holding investment competitions, and providing information exchange. Russian and international research centers and universities will be invited to partner with
Laboratory facilities for bio medical research in skolkovo. what is needed –g...Albert Yefimov
The document discusses the development of Centers for Shared Facilities (CSFs) or Centers of Excellence (CoE) as key elements of the biomedical technology innovation ecosystem in Skolkovo. It proposes establishing 10 CSFs by 2014 to provide infrastructure, expertise, and services to residents and partners. In 2011, the focus will be on developing 3 initial CSFs, procuring equipment, and establishing educational programs to prepare for full operations by 2012-2013. CSFs will be self-sufficient sectors that can integrate into the future Skolkovo Technopark and University.
The document outlines a proposed project called "Feeding Knowledge" which aims to create an international network to promote research and innovation on food security. The project would establish an international scientific network, train young experts, develop policies to meet Third World country needs, and create an international technology platform as a hub for collaboration. The platform would collect and organize data, build knowledge, develop networks to understand and solve issues, and integrate people, tools and information through various functions and tools. The project's governance structure and costs are also summarized.
Presented by Claudia Stein, Director, Division of Information, Evidence, Research and Innovation, WHO/Europe, at the 64th session of the WHO Regional Committee for Europe.
Strengthening research. development and innovation cooperation between jordan...SRTD _ II
Erika Sela from INNOVATEC gave a presentation on her experience participating in EU framework programmes and providing advice to Jordanian researchers. She discussed INNOVATEC's work coordinating and partnering on EU-funded health projects. She described two projects she coordinated, including developing new methodologies to monitor health interventions. She outlined funding options for Jordanian health groups in H2020 and suggested networking with European researchers, making research visible, and using platforms like CORDIS to find partners. She emphasized that international collaboration is growing to address global challenges and encouraged pursuing bilateral and regional cooperation opportunities.
Vladimir Eryomin, Rus-Technol-Platforms,Vienna, 4-February-2010Vladimir ERYOMIN
Dr. Vladimir Eryomin, Bio-NCP of Russia, email: eryomin@inbi.ras.ru
Scientific Officer: Dr. Elisabetta Balzi, email: Elisabetta.Balzi@ec.europa.eu
Expected impact: Development of new computational tools for rational enzyme design and
improved industrial biocatalysts. Contribution to EU-Russia S&T cooperation.
Vladimir Eryomin, Russ S&T-Cooperation-in-FP7, Kiev-Ukraine, 23-September-2009Vladimir ERYOMIN
The document outlines Vladimir Eryomin's presentation on Russia's experience participating successfully in the EU's FP7 program. It describes the creation and activities of Russia's Bio-NCP, the formation of Russian technology platforms aligned with the EU's knowledge-based bioeconomy concept, and examples of EU-Russia cooperation including working groups and coordinated calls for proposals.
Presentation done at CBEB'16 the 17th October by Vicente Traver introducing EIP-AHA and H2020 policies, the LINK project and different opportunities to cooperate together between Brazil and EU about telehealth and personal health
General presentation Luxembourg BioHealth ClusterLuxBioHealth
The document provides an overview of the Luxembourg BioHealth Cluster. It discusses Luxembourg's investment in the biohealth sector to diversify its economy and become the healthiest country. The strategy includes launching a government initiative in 2008 to develop molecular diagnostics. It outlines the cluster's vision, members, both public and private players, and upcoming events to promote innovation and internationalization in the biohealth field.
Igor Goryanin biomedical technologies at Skolkovoigorod
The document discusses potential priority areas for biomedical technologies at Skolkovo in Russia. Oncology, vaccines and anti-infectives, and cardiovascular products are identified as higher priority areas in bio-healthcare/biopharma. Bioinformatics areas like molecular medicine, DNA sequencing, and drug development are also prioritized. Lower priority bioindustrial areas include plant extracts, bioremediation, marine biotech, and biomass. The document analyzes each area's feasibility, attractiveness, market size, and strategic fit for Skolkovo.
The document summarizes the St. Petersburg International Forum on Pharmacy, Medical Equipment, and Biotechnology held in April 2012. Over 1,000 participants from Russia and abroad attended to discuss innovative development in the pharmaceutical, biotechnology, and medical industries. Key topics included attracting investment, introducing new technologies, and promoting locally made products internationally. The forum featured business programs, exhibitions, tours, and award ceremonies recognizing achievements in these fields. It aimed to facilitate cooperation to advance the regional medical and pharmaceutical cluster in St. Petersburg. Plans were announced for the next IPhEB forum to be held in April 2013.
The document proposes Italy's contribution to the LifeWatch eScience infrastructure through the establishment of an E-Biodiversity Research Institute. The institute would serve as Italy's distributed LifeWatch center and host the central Service Centre. It would be organized into departments focused on management, IT services, training, biological research, and outreach. The research unit would consist of distributed Virtual Laboratories in key areas like biomolecular research, collections, interactions, and the Mediterranean region. The institute aims to strengthen biodiversity research, optimize funding, identify knowledge gaps, support various sectors, and increase awareness of biodiversity's importance through an integrative eScience approach.
Presentation "Innovating for Health and Well-being" at WHO International Healthy Cities conference, Athens, Greece, 25/OCT/2014, Arto Holopainen, Development Director, Kuopio Innovation Ltd.
The document provides information about the Organization for Economic Co-operation and Development (OECD). It discusses the history and establishment of the OECD, its objectives to promote policies that improve economic and social well-being, and how it provides a forum for governments to work together on issues like economic growth, employment, financial stability, and trade. The document also summarizes OECD's toxicity testing guidelines, which provide standardized methods for testing chemicals and their potential hazards. This allows data to be shared between countries and avoids duplicative testing.
The document discusses moving forward with generic laboratory strengthening activities in the areas of laboratory quality and biosafety. It outlines proposed joint activities between ECDC and NMFPs, including developing project plans and collaboration proposals with partners like WHO Europe and EBSA. Feedback from NMFPs would be consolidated to secure funding for 2017-2018 activities. These may include training modules, workshops, and other capacity building opportunities to strengthen laboratory systems across Europe. NMFPs would provide input on the relevance and feasibility of the proposed activities to support public health microbiology in their countries.
TCI 2013 BioBasque and the Basque BioClusterTCI Network
The BioBasque cluster was established in 2001 with the goal of developing a new life sciences industry in the Basque Country through knowledge generation, business development, and sector dynamization. It has grown to include over 60 companies employing over 1,600 people in R&D and generating over 300 million euros in revenue annually. Many of the companies specialize in areas like diagnostics, therapeutics, drug development, and medical devices. The cluster's success demonstrates that targeted investment in science-based industry can drive productive transformation and economic growth in a region.
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI
This document discusses increasing patient involvement in medical research and development. It notes that the medical landscape is transforming rapidly through innovations like personalized medicine and biomarkers. While this benefits patients, it also means smaller trial populations and a need for more post-marketing data. The document advocates for increasing patient involvement in areas like clinical trial design, setting research priorities, measuring quality of life, and pharmaceutical policy. It highlights the European Patients' Academy (EUPATI) project, which aims to empower patients through education on medical research and development processes in order to facilitate greater patient engagement.
The Asia eHealth Information Network (AeHIN) is a peer-to-peer network of over 700 members from 25 countries that aims to support national eHealth development in Asia. AeHIN proposes a strategic roadmap for 2016-2020 that includes adopting IT governance frameworks and eHealth blueprints at the country level to guide development, strengthening institutional capacity for collecting and sharing health data according to international standards, and maximizing the use of data through open standards to improve decision making. AeHIN also plans to continue strengthening the network through training programs, collaborative projects, and convergence workshops to facilitate sharing of best practices and lessons learned.
RUbiomed is a community of biotechnology and medical professionals working on the Skolkovo Foundation Biomedicine Cluster platform. Its mission is to contribute to the successful development of Russian science and enterprise in these fields by creating a platform to connect entrepreneurs, experts, investors and government. This will help establish cooperation between science, business and government. The goals are to create conditions for successful communication, ensure access to capital and resources, organize educational programs, and support the formation of a class of qualified experts. Objectives include forming an ecosystem conducive to innovation, establishing shared research centers, supporting members' projects, holding investment competitions, and providing information exchange. Russian and international research centers and universities will be invited to partner with
Laboratory facilities for bio medical research in skolkovo. what is needed –g...Albert Yefimov
The document discusses the development of Centers for Shared Facilities (CSFs) or Centers of Excellence (CoE) as key elements of the biomedical technology innovation ecosystem in Skolkovo. It proposes establishing 10 CSFs by 2014 to provide infrastructure, expertise, and services to residents and partners. In 2011, the focus will be on developing 3 initial CSFs, procuring equipment, and establishing educational programs to prepare for full operations by 2012-2013. CSFs will be self-sufficient sectors that can integrate into the future Skolkovo Technopark and University.
The document outlines a proposed project called "Feeding Knowledge" which aims to create an international network to promote research and innovation on food security. The project would establish an international scientific network, train young experts, develop policies to meet Third World country needs, and create an international technology platform as a hub for collaboration. The platform would collect and organize data, build knowledge, develop networks to understand and solve issues, and integrate people, tools and information through various functions and tools. The project's governance structure and costs are also summarized.
Presented by Claudia Stein, Director, Division of Information, Evidence, Research and Innovation, WHO/Europe, at the 64th session of the WHO Regional Committee for Europe.
Strengthening research. development and innovation cooperation between jordan...SRTD _ II
Erika Sela from INNOVATEC gave a presentation on her experience participating in EU framework programmes and providing advice to Jordanian researchers. She discussed INNOVATEC's work coordinating and partnering on EU-funded health projects. She described two projects she coordinated, including developing new methodologies to monitor health interventions. She outlined funding options for Jordanian health groups in H2020 and suggested networking with European researchers, making research visible, and using platforms like CORDIS to find partners. She emphasized that international collaboration is growing to address global challenges and encouraged pursuing bilateral and regional cooperation opportunities.
Vladimir Eryomin, Rus-Technol-Platforms,Vienna, 4-February-2010Vladimir ERYOMIN
Dr. Vladimir Eryomin, Bio-NCP of Russia, email: eryomin@inbi.ras.ru
Scientific Officer: Dr. Elisabetta Balzi, email: Elisabetta.Balzi@ec.europa.eu
Expected impact: Development of new computational tools for rational enzyme design and
improved industrial biocatalysts. Contribution to EU-Russia S&T cooperation.
Vladimir Eryomin, Russ S&T-Cooperation-in-FP7, Kiev-Ukraine, 23-September-2009Vladimir ERYOMIN
The document outlines Vladimir Eryomin's presentation on Russia's experience participating successfully in the EU's FP7 program. It describes the creation and activities of Russia's Bio-NCP, the formation of Russian technology platforms aligned with the EU's knowledge-based bioeconomy concept, and examples of EU-Russia cooperation including working groups and coordinated calls for proposals.
Presentation done at CBEB'16 the 17th October by Vicente Traver introducing EIP-AHA and H2020 policies, the LINK project and different opportunities to cooperate together between Brazil and EU about telehealth and personal health
General presentation Luxembourg BioHealth ClusterLuxBioHealth
The document provides an overview of the Luxembourg BioHealth Cluster. It discusses Luxembourg's investment in the biohealth sector to diversify its economy and become the healthiest country. The strategy includes launching a government initiative in 2008 to develop molecular diagnostics. It outlines the cluster's vision, members, both public and private players, and upcoming events to promote innovation and internationalization in the biohealth field.
Igor Goryanin biomedical technologies at Skolkovoigorod
The document discusses potential priority areas for biomedical technologies at Skolkovo in Russia. Oncology, vaccines and anti-infectives, and cardiovascular products are identified as higher priority areas in bio-healthcare/biopharma. Bioinformatics areas like molecular medicine, DNA sequencing, and drug development are also prioritized. Lower priority bioindustrial areas include plant extracts, bioremediation, marine biotech, and biomass. The document analyzes each area's feasibility, attractiveness, market size, and strategic fit for Skolkovo.
The document summarizes the St. Petersburg International Forum on Pharmacy, Medical Equipment, and Biotechnology held in April 2012. Over 1,000 participants from Russia and abroad attended to discuss innovative development in the pharmaceutical, biotechnology, and medical industries. Key topics included attracting investment, introducing new technologies, and promoting locally made products internationally. The forum featured business programs, exhibitions, tours, and award ceremonies recognizing achievements in these fields. It aimed to facilitate cooperation to advance the regional medical and pharmaceutical cluster in St. Petersburg. Plans were announced for the next IPhEB forum to be held in April 2013.
The document proposes Italy's contribution to the LifeWatch eScience infrastructure through the establishment of an E-Biodiversity Research Institute. The institute would serve as Italy's distributed LifeWatch center and host the central Service Centre. It would be organized into departments focused on management, IT services, training, biological research, and outreach. The research unit would consist of distributed Virtual Laboratories in key areas like biomolecular research, collections, interactions, and the Mediterranean region. The institute aims to strengthen biodiversity research, optimize funding, identify knowledge gaps, support various sectors, and increase awareness of biodiversity's importance through an integrative eScience approach.
Presentation "Innovating for Health and Well-being" at WHO International Healthy Cities conference, Athens, Greece, 25/OCT/2014, Arto Holopainen, Development Director, Kuopio Innovation Ltd.
The document provides information about the Organization for Economic Co-operation and Development (OECD). It discusses the history and establishment of the OECD, its objectives to promote policies that improve economic and social well-being, and how it provides a forum for governments to work together on issues like economic growth, employment, financial stability, and trade. The document also summarizes OECD's toxicity testing guidelines, which provide standardized methods for testing chemicals and their potential hazards. This allows data to be shared between countries and avoids duplicative testing.
The document discusses moving forward with generic laboratory strengthening activities in the areas of laboratory quality and biosafety. It outlines proposed joint activities between ECDC and NMFPs, including developing project plans and collaboration proposals with partners like WHO Europe and EBSA. Feedback from NMFPs would be consolidated to secure funding for 2017-2018 activities. These may include training modules, workshops, and other capacity building opportunities to strengthen laboratory systems across Europe. NMFPs would provide input on the relevance and feasibility of the proposed activities to support public health microbiology in their countries.
TCI 2013 BioBasque and the Basque BioClusterTCI Network
The BioBasque cluster was established in 2001 with the goal of developing a new life sciences industry in the Basque Country through knowledge generation, business development, and sector dynamization. It has grown to include over 60 companies employing over 1,600 people in R&D and generating over 300 million euros in revenue annually. Many of the companies specialize in areas like diagnostics, therapeutics, drug development, and medical devices. The cluster's success demonstrates that targeted investment in science-based industry can drive productive transformation and economic growth in a region.
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI
This document discusses increasing patient involvement in medical research and development. It notes that the medical landscape is transforming rapidly through innovations like personalized medicine and biomarkers. While this benefits patients, it also means smaller trial populations and a need for more post-marketing data. The document advocates for increasing patient involvement in areas like clinical trial design, setting research priorities, measuring quality of life, and pharmaceutical policy. It highlights the European Patients' Academy (EUPATI) project, which aims to empower patients through education on medical research and development processes in order to facilitate greater patient engagement.
The Asia eHealth Information Network (AeHIN) is a peer-to-peer network of over 700 members from 25 countries that aims to support national eHealth development in Asia. AeHIN proposes a strategic roadmap for 2016-2020 that includes adopting IT governance frameworks and eHealth blueprints at the country level to guide development, strengthening institutional capacity for collecting and sharing health data according to international standards, and maximizing the use of data through open standards to improve decision making. AeHIN also plans to continue strengthening the network through training programs, collaborative projects, and convergence workshops to facilitate sharing of best practices and lessons learned.
Состояние и перспективы российской робототехникиAlbert Yefimov
Слайды к докладу Альберта Ефимова, руководителя робоцентра Сколково на Координационном совете по развитию робототехники Министерства Образования и Науки России 08 апреля 2016 года
The document discusses Skolkovo Robotic Center's participation at the Innorobo 2015 exhibition. Several Russian robotics companies with ties to Skolkovo Robotic Center were highlighted, including EzoAtlet, Promobot, Wikron, Lexy, TRIK, and TSURU. The companies demonstrated medical exoskeletons, service robots, telepresence robots, and robot constructors. Participating helped to promote commercialization of Russian robotics technologies and sales to European markets.
Russian Robotics: Jumpstarting to re-industrialisation with Skolkovo Albert Yefimov
The document discusses the potential of robotics to become the next general purpose technology and drive re-industrialization in Russia. It outlines how robotics can address challenges like declining productivity, aging populations, and dangerous jobs. The Skolkovo Robotics Center in Russia aims to capitalize on the country's engineering talent and create opportunities in robotics startups. The Center focuses on improving cognition/navigation, human-machine interfaces, human augmentation, and medical robotics.
How are Lilac French Bulldogs Beauty Charming the World and Capturing Hearts....Lacey Max
“After being the most listed dog breed in the United States for 31
years in a row, the Labrador Retriever has dropped to second place
in the American Kennel Club's annual survey of the country's most
popular canines. The French Bulldog is the new top dog in the
United States as of 2022. The stylish puppy has ascended the
rankings in rapid time despite having health concerns and limited
color choices.”
Profiles of Iconic Fashion Personalities.pdfTTop Threads
The fashion industry is dynamic and ever-changing, continuously sculpted by trailblazing visionaries who challenge norms and redefine beauty. This document delves into the profiles of some of the most iconic fashion personalities whose impact has left a lasting impression on the industry. From timeless designers to modern-day influencers, each individual has uniquely woven their thread into the rich fabric of fashion history, contributing to its ongoing evolution.
Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...my Pandit
Explore the fascinating world of the Gemini Zodiac Sign. Discover the unique personality traits, key dates, and horoscope insights of Gemini individuals. Learn how their sociable, communicative nature and boundless curiosity make them the dynamic explorers of the zodiac. Dive into the duality of the Gemini sign and understand their intellectual and adventurous spirit.
Zodiac Signs and Food Preferences_ What Your Sign Says About Your Tastemy Pandit
Know what your zodiac sign says about your taste in food! Explore how the 12 zodiac signs influence your culinary preferences with insights from MyPandit. Dive into astrology and flavors!
Storytelling is an incredibly valuable tool to share data and information. To get the most impact from stories there are a number of key ingredients. These are based on science and human nature. Using these elements in a story you can deliver information impactfully, ensure action and drive change.
SATTA MATKA DPBOSS KALYAN MATKA RESULTS KALYAN CHART KALYAN MATKA MATKA RESULT KALYAN MATKA TIPS SATTA MATKA MATKA COM MATKA PANA JODI TODAY BATTA SATKA MATKA PATTI JODI NUMBER MATKA RESULTS MATKA CHART MATKA JODI SATTA COM INDIA SATTA MATKA MATKA TIPS MATKA WAPKA ALL MATKA RESULT LIVE ONLINE MATKA RESULT KALYAN MATKA RESULT DPBOSS MATKA 143 MAIN MATKA KALYAN MATKA RESULTS KALYAN CHART
AI Transformation Playbook: Thinking AI-First for Your BusinessArijit Dutta
I dive into how businesses can stay competitive by integrating AI into their core processes. From identifying the right approach to building collaborative teams and recognizing common pitfalls, this guide has got you covered. AI transformation is a journey, and this playbook is here to help you navigate it successfully.
Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...Niswey
50 million companies worldwide leverage WhatsApp as a key marketing channel. You may have considered adding it to your marketing mix, or probably already driving impressive conversions with WhatsApp.
But wait. What happens when you fully integrate your WhatsApp campaigns with HubSpot?
That's exactly what we explored in this session.
We take a look at everything that you need to know in order to deploy effective WhatsApp marketing strategies, and integrate it with your buyer journey in HubSpot. From technical requirements to innovative campaign strategies, to advanced campaign reporting - we discuss all that and more, to leverage WhatsApp for maximum impact. Check out more details about the event here https://events.hubspot.com/events/details/hubspot-new-delhi-presents-unlocking-whatsapp-marketing-with-hubspot-integrating-messaging-into-your-marketing-strategy/
Satta matka fixx jodi panna all market dpboss matka guessing fixx panna jodi kalyan and all market game liss cover now 420 matka office mumbai maharashtra india fixx jodi panna
Call me 9040963354
WhatsApp 9040963354
SATTA MATKA DPBOSS KALYAN MATKA RESULTS KALYAN CHART KALYAN MATKA MATKA RESULT KALYAN MATKA TIPS SATTA MATKA MATKA COM MATKA PANA JODI TODAY BATTA SATKA MATKA PATTI JODI NUMBER MATKA RESULTS MATKA CHART MATKA JODI SATTA COM INDIA SATTA MATKA MATKA TIPS MATKA WAPKA ALL MATKA RESULT LIVE ONLINE MATKA RESULT KALYAN MATKA RESULT DPBOSS MATKA 143 MAIN MATKA KALYAN MATKA RESULTS KALYAN CHART
SATTA MATKA SATTA FAST RESULT KALYAN TOP MATKA RESULT KALYAN SATTA MATKA FAST RESULT MILAN RATAN RAJDHANI MAIN BAZAR MATKA FAST TIPS RESULT MATKA CHART JODI CHART PANEL CHART FREE FIX GAME SATTAMATKA ! MATKA MOBI SATTA 143 spboss.in TOP NO1 RESULT FULL RATE MATKA ONLINE GAME PLAY BY APP SPBOSS
Part 2 Deep Dive: Navigating the 2024 Slowdownjeffkluth1
Introduction
The global retail industry has weathered numerous storms, with the financial crisis of 2008 serving as a poignant reminder of the sector's resilience and adaptability. However, as we navigate the complex landscape of 2024, retailers face a unique set of challenges that demand innovative strategies and a fundamental shift in mindset. This white paper contrasts the impact of the 2008 recession on the retail sector with the current headwinds retailers are grappling with, while offering a comprehensive roadmap for success in this new paradigm.
The Genesis of BriansClub.cm Famous Dark WEb PlatformSabaaSudozai
BriansClub.cm, a famous platform on the dark web, has become one of the most infamous carding marketplaces, specializing in the sale of stolen credit card data.
NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...BBPMedia1
Nathalie zal delen hoe DEI en ESG een fundamentele rol kunnen spelen in je merkstrategie en je de juiste aansluiting kan creëren met je doelgroep. Door middel van voorbeelden en simpele handvatten toont ze hoe dit in jouw organisatie toegepast kan worden.
2. Five key elements of the BMT innovation ecosystem
Community of
BMT residents
InfrastructuresRegulatory environment
Training / Educational
Programs
BMT Ecosystem.
5
4 3
2
1
Business incubators
Venture Capital Funds
Strategic industrial
investors
Institutional Partners
Experts
Residents of the cluster
(project companies)
Association of the resident’s
partners (biomedical and
pharmaceutical clusters)
Center for formalizing of IP
Policy
Service Center of support
of the Cluster residents (tax,
legal, customs consultants)
Infrastructure link-
laboratories
Centers for Shared
Facilities (CSF), or Centers
of Excellence (CoE)
R & D centers . Key
partners
SIST (educational programs)
International traineeship
Internships
International
Conferences/Roadshows
Institutes of
commercialization
1
3. Cooperation with Government of the Russian Federation
2
April 2001: Agreement, on cooperation
and coordination of joint activities in
the innovative development of health signed .
•May 2011: Coordinating Council for Biomedical
Technologies established
The Ministry
of Health and
Social
Development
Ministry
of Industry and
Trade
Status of relationship Development plan
• March 2011: Working group (on coordination of
joint activity in the field was established.
•June 2011: Head of Cluster BMT elected to join
the Working Group of the Commission on
Modernization and Technological
Development under the management of RF
President .
▪ Joint expertise and support of innovative
projects.
▪ Creation of a single register of the biomed
projects..
▪ Joint participation in the development
of biomedical CSF’s and CEOs
▪ Unified information platforms
Ministry of
Economic
Development
February - May 2011:
• Working Group on the development of the
Law ”Cellular technology”
• Platform "Medicines of the Future“
• Working Group “Drug manufacturing and R&D “
with the Commission on Modernization and
Technical development under the management of RF
President .
▪ Active participation and implementation
of proposals of the Skolkovo Fund in
Interdepartmental governmental
Working Groups and committees on
Biomedicine and biopharmaceuticals
• Joint expertise and support of innovative
projects
•Joint participation in CSFs of Excellence
•Coordination in priorities of innovation
•Unified information platforms
Partners
4. Cooperation with institutional partners
3
•March 2011: Agreements with Infrastructural RVC
Venture Funds: Biofund RVC, Maxwell Biotech,
BioProcess Capital Ventures - were signed.
• May 2011: Joint expertise and structuring of
7 projects
•Structuring of possible RVC participation . CSF
"Preclinical studies with GLP standards”
▪ Co-financing of at least 3 projects in
conjunction with RVC Funds.
▪ Participation of RVC Funds in
one of CSF .
JSC “RVC”
JSC “RUSNANO”
March 2011г: Agreement of creation Coordinating
Council for Biomedical Technologies was signed.
April - May 2011: Joint expertise and structuring of 3
projects with "ROSNANO
April-May 2011: Jjoint (with IGB RAS), educational
module, "System analysis of genomic data”, in
collaboration with Cold Spring Harbor Laboratory (USA)
▪ Joint projects directory.
▪ Co-financing of at least 2 projects
▪ Starting with
2 joint educational practice-
oriented modules .
EMBL (European
Molecular Biology
Laboratories ) -
European leading
interstate Centre for
Molecular Biology
• April 2011: Agreement with the EMBL was signed.
•April - May 2011: Consultations on the
establishment of of EMBL R&D Institute in Skolkovo
•April - May 2011: Participation of the EMBL in the
CSF "Structural biology ” (in collaboration with
the MIPT and ONEXIM Group)
▪ Participation of EMBL in
CSF "Structural biology in
collaboration with
the MIPT and ONEXIM Group)
▪ EMBL R&D Institute
▪ in Skolkovo
▪ Joint training courses
Status of relationship Development planPartners
5. Cooperation with regional biomedicine and biopharmaceutical
clusters
4
Feb 2011 Agreement of joining the BMT
Cluster to the Supervisory Board of the
BFC “Severny“ signed
Feb-May 2011 Joint educational program
Apr-May 2011 Some of the BFC
“Severny” participants got the resident
status
▪ MIPT
▪ Chemrar
▪ PROTEK
▪ Pharmzashita
▪ Akrikhin
Biopharmcluster
“Severny”
(MIPT)
Status of relationship Participants Development plan
▪ Joint support for the best
innovative projects of BFC
“Severny”
▪ Using best practices (a business
incubator, technopark, CSF,
educational programs) i
Ural Pharmcluster
Kalugsky
Pharmcluster
Feb 2011 Agreement of the Supervisory
Board of the Ural Pharmcluster signed
Feb-May 2011 Examination of joint
projects
Apr 2011 Some of the Ural Pharmcluster
participants get the resident status of the
Fund
▪ Zavod Medsintez LLC
▪ IOS RAS
▪ Zavod Dizet LLC
▪ Unona Holding
Company
▪ Joint support for the best
innovative projects
▪ Using the regional practices
May 2011 Agreement of joining the BMT
Cluster to the Kalugsky Pharmcluster
“Innovative biopharmaceutics” signed
▪ «Hemofarm» (STADA,
Germany)
▪ «Berlin-
Chemie/Menarini» (Italy)
▪ «Novo Nordisk»
(Denmark)
▪ Astra Zeneca (UK)
▪ Joint support for the best
innovative projects
▪ CSF in Nuclear Medicine
Partners
6. Creating the «educational environment» within the BMT Сluster
5
Molecular genetics
Synthetic biology
System bioinformatics
Cluster’s link-
laboratories
Cluster’s project
companies (and their
scientific partners)
«Bortnic’s
Fund»
External special system specialized
scientific knowledge providers
“Skolkovo” University Biomedical faculty
External personnel source for to
organize the participation in the
educational programs
Educational module
Providers of the systematic and
scientific knowledge and practices
Latest methodology of the
Oncology diagnostics and therapy
Latest medical cell technologies
Cluster’s CSF’s
Educational module
Educational module
Educational module
Educational module
practice
practice
practice
practice
practice
Providers of the infrastructural platform for the lecture
courses and the practice seminars holding on
RUSNANO
RVC
Ministry of
the
Healthcare
Provider of the
consumers for
the system
knowledge
BMT cluster
Russian partners: the universities and he
R&D centers
Foreign university partners
Providers of the best educational practices
System biopharmaceutics Educational module practice
7. Educational Programs of BMT Cluster
6
March 2011 The final of the first session of
the qualifying competition program. The
program, “The Talent pool of young scientists
of BMT Cluster “ (UMNIK-Skolkovets), in
which 34 young professionals were selected,Bortnik’s Fund
RUSNANO, Institute
of Gene, Cold Spring
Harbor Laboratory
Status of relationship Development Plan
March-May 2011 Practice-oriented educational
module of “Statistical analysis of genomic data”
is under testing
May 2011 first students (BMT Cluster residents,
RUSSNANO project companies, MIPT students,
“Umnik-Skolkovets” graduates)
▪ Integration of the “Statistical analysis of genomic
data” into CSF for “Medicine bioinformatics” of
BMT Cluster
▪ Development. testing and, running of a new
educational programs
ASTRA ZENECA Co
(UK)
March 2011 BMT Cluster joining Supervisory Board
of «Knowledge Vanguard» Virtual University,
established by Astra Zeneca with the participation
of RUSNANO, RVC, the Ministry of Health and
Social Development of Russia
April 2011: Applications expertise within the
competition of research projects in cardiology and
oncology
•Conducting 2nd session of the "Talent Pool“
program
•Choosing of the foreign universities-partners, the
agreements signing for training of young
scientists, graduates of "UMNIK-Skolkovets”,
student exchange programs, development of
internship programs and trainings
Partners
▪ Completion of the contest and awarding the
winners.
▪ Involvement of the winners in the educational and
grant programs of BMT Cluster.
▪ Development of ASTRA ZENECA’s training
programs in within the framework of the
Coordinating Council of BMT Cluster and the
Ministry of Health and Social Development of
Russia
8. Projects of Biomed Cluster (20/6)
7
PROJECT TITLE FORESIGHT
PROJECT BUDGET,
MM RUB
AMOUNT FROM THE FUND
APPROVED, MM RUB (2011-
2013)
AMOUNT OF 1ST
TRANCHE, MM
RUB
SYNTHETIC PEPTIDE DRUGS BIO-PHARMA 795 675 170
PHOTOBIOLOGICAL MICROBIAL FCELLS BIO-INDUSTRIALS 600 420 90
DEVELOPMENT OF NOVEL ANTI-HYPOXIA-
ADENOSINERGIC TECHNOLOGIES, DRUGS AND
VACCINES FOR THE TREATMENT OF CANCER,
INFECTIOUS DISEASES AND SEPSIS
BIO-PHARMA 240 200 74
DEVELOPMENT OF AUTHENTIC MEDICINAL DRUGS FOR
THE TREATMENT OF INFECTIOUS DISEASES OF VIRAL
AETIOLOGY AND DEVELOPMENT OF DIAGNOSTIC
METHODS FOR VIRUS DISEASES
BIO-PHARMA 960 400 130
BIOTECHNOLOGY DETECTING AND NEUTRALIZING
DANGEROUS INFECTIOUS AGENTS
BIO-HEALTHCARE 420 220 77
DEVELOPMENT OF BIODEGRADABLE POLYMER
INTRACORONARY IMPLANTS
BIO-HEALTHCARE 105 69 21
TOTAL: 1984 562
FINANCING WERE APPROVED BY INVESTMENT COMMITTEE FOR SIX PROJECTS
9. Projects of Biomed Cluster
8
PROJECT TITLE FORESIGHT COMPANY
PHARMACEUTICALS FROM THE MODIFIED BIOPOLYMER CARBOHYDRATES BIO-PHARMA VOSTOKFARM INNOVATIONS LLC
TARGETED MULTIMODAL DIAGNOSTIC AND THERAPEUTIC AGENTS ON THE
CARRIER OF "CORE-CARBON SHELL“ STRUCTURE
BIO-PHARMA
URAL NUCLEAR MEDICINE CENTER
LLC
DEVELOPMENT OF A NEW LINE OF BIOLOGICAL PRODUCTS ON THE BASIS OF
CORD BLOOD STEM CELLS FOR TREATMENT OF ONCOLOGICAL AND
HEMATOLOGICAL PATIENTS AFTER CHEMO-AND RADIOTHERAPY, USING THE
METHODS OF IMMUNOMAGNETIC SEPARATION, CULTURING, GENETIC TESTING,
EVALUATION OF TELOMERASE ACTIVITY, CRYOPRESERVATION
BIO-HEALTHCARE CELLULAR INNOVATIONS LLC
DEVELOPMENT AND IMPLEMENTATION OF A PERSONALIZED DIAGNOSIS AND
TREATMENT OF ONCOLOGICAL DISEASES
BIO-HEALTHCARE UNIVERSAL BIOSYSTEMS LLC
DEVELOPMENT AND COMMERCIALIZATION OF INNOVATIVE TARGETED DRUG
FOR THE TREATMENT OF KIDNEY CANCER
BIO-PHARMA ONKOMAKS LLC
LACTOFERRIN AND OTHER REGULATORY AND THERAPEUTIC HUMAN PROTEINS
FROM TRANSGENIC GOATS’ MILK. DEVELOPING SCIENTIFIC AND
TECHNOLOGICAL BASIS FOR A BIO-TECH TRANSGENIC INDUSTRY IN RUSSIA
BIO-HEALTHCARE TRANSGENFARM LLC
DEVELOPMENT OF A MODEL OF VENOUS VALVE PROSTHESIS BIO-HEALTHCARE SPC AMFION LLC
FIFTEEN PROJECTS RECEIVED PARTICIPANT CERTIFICATE
10. Projects of Biomed Cluster
9
PROJECT TITLE FORESIGHT COMPANY
DEVELOPMENT OF PHARMACEUTICALS FOR TREATMENT OF BACTERIAL AND
FUNGAL INFECTIONS ON THE BASIS OF THE PATENTED ANALOG NATURAL
PEPTIDE LL-37
BIO-PHARMA BIOCHART LLC
DEVELOPMENT AND COMMERCIALIZATION OF NOVEL DRUG FOR
MULTIDRUGRESISTANT TUBERCULOSIS TREATMENT
BIO-PHARMA INFEKTEKS LLC
DEVELOPMENT OF NEW PHARMACEUTICAL COMPOSITIONS AND DRUGS FOR
THE TREATMENT OF NEUROLOGICAL DISEASES
BIO-PHARMA LEKSYSTEMS LLC
DEVELOPMENT OF THE NEW DRUGS BASED ON DERIVATIVES OF N-ACYL
BIOGENIC AMINES AND THEIR ANALOGUES
BIO-PHARMA FARMALLIANCE LLC
ANTIVIRAL DRUGS DEVELOPMENT BASED ON INHIBITION OF MATRIX PROTEINS BIO-PHARMA QUANTUM PHARMACEUTICALS
DEVELOPMENT OF PHARMACEUTICAL COMPOSITION (CMX-157) FOR
TREATMENT AND PREVENTION OF HIV INFECTION INCLUDING HIGH-RESISTANT
FORMS
BIO-PHARMA HELIX VENTURES
Information platform for biomedical research BIOINFORMATICS BIOSOFT.RU LLC
DEVELOPMENT OF BRAIN-COMPUTER INTERFACE TECHNOLOGY FOR
PROSTHETIC LIMBS AND MANIPULATORS CONTROL
BIO-HEALTHCARE INNOVATION TECHNOLOGIES LLC
FIFTEEN PROJECTS RECEIVED PARTICIPANT CERTIFICATE
11. 10
Leading Universities
Major biomed and pharmaceutical companies
Regional Pharma Clusters
Ural PharmCluster (Yekaterinburg)
Pharm Cluster Severny (North of Moscow)
Institutional partners
Collaboration with key partners
Agreement will be
signed Jun, 17 ($15M)
Agreement will be
signed soon (15FTE in
R&D M&S Centre)
General MoU
General MoU
13. CSFs and the BMT foresights. Equipment and competencies
Early development Lead optimization Preclinical Clinical - Registration and launch
Transgenomic and postgenomic technologies
Foresight.
Biomedicine
and Bio-
pharmaceutics
Complex modeling and simulation. Biomedical Informatics
«Proteomics , and other omics
Preclinical and clinical studies. P4 Medicine. Cancer
)
Foresight
Bioinformatics
Preclinical. GLPStructural Biology»
Directed evolution Artificial
ecosystems
Scaling upй Foresight
Industrial biotechnologies
Synthetic biology
Regenerative medicine
«
AB and other novel therapies
Infection diseases»
12
14. Basic Principles of BMT CSF functioning
CSF research areas should be in the BMT foresights. CSF should provide services,
research and educational programmes
1)
Capital expenses for major consumables and equipment are covered by the Fund.
Operational budget to be provided by residents companies and external customers.
Infrastructure facilities, the equipment and maintenance services of CSFs are to be 100%
owned by the Skolkovo Foundation or/and its wholly owned subsidiary.
3)
Residents of the Skolkovo should have a first right to use CSFs services and competencies.
There should be a strong demand for competences of CSF
4)
CSF should provide and maintain excellence in access to modern biomedical equipment,
research infrastructure, highly qualified staff, and services on the world level
5)
2)
CSF establishment in the field of interest is supported by independent scientific experts6)
13
15. Using existing competencies and adding novel ones.
Research and Development
Existing equipment New Equipment
BMT CSF
Existing methodologies and techniques
Staff Skills and experience
Commercialisation experience
Existing scientific collaborations
Project companies. CSF customers
New qualified staff
Key partners
Effective management
Innovation projects
Educational and retraining
programmes
14
Services
16. ResidentsInfrastructuresUniversityInvestors
Regulatory
environment
20142012 - 20132011
Infrastructural Link-Labs (Project
based).
Centers for Shared Facilities (CSF) or CoE
Functioning of the BMT infrastructural Ecosystem
Educational programs based on the project companies
community and infrastructure partners
Creation of Departments of Skolkovo University
Projects
Link-labs are based
on project companies
activities
Part of the R & D
centers establishes on
the basis of Centers
for Shared FacilitiesR & D centers with key partners
Develop and implement the modules of special lectures and
seminars (including "remote web – courses”)
Co-investors and strategic projects partners
Venture Capital Funds
Institutional Partners
(RUSNANO, RVC, VEB)
Creating a network of business incubators
Long-term relationships with strategic investors
Support by the functional units of the Fund
Creation of service centers of legal assistance based on
Techno park
BMT CSF development pipeline
15
17. BMT CSF Example. Management
CSF Advisory Council
CSF Director
Sector Head
Director R&D R&D
Educational and training courses
Sector Head Sector Head Sector Head
CSF Scientific Council
Director. Training
Director. Services Services. Customers
Skolkovo Foundation
Administration.
IP Centre
CSF advisory council: responsibilities
• Budget control. Finance
• Administration. Planning.
• R&D and other services management
• Co-investment and other grants management
Collaborative Agreements include
• Temporal leasing of the equipment to key
collaborators/owners of buildings.
• Major principles of the access and usage of the
equipment.
16
18. 17
BMT CSF. Example of general organisational structure
Owners of infrastructure and buildings (Main collaborators)
The Skolkovo Fund budget
Fund subsidiary company
R&D Budget:
Salaries for engineers and scientists
working on the Fund equipment
Equipment
BMT cluster
Consumables for the Fund equipment
Budget form Fund project companies
Budget of resident companies
Budget of main collaboratorsExisting equipment
Unified equipment facilities
Staff Existing best practicesInfrustructure
Skolkovo Fund. Cluster BMT.
Technopark
Skolkovo University. Skolkovo Open University
R&D
Service provider for Fund residents and Fund project companies
Training programmes
Ph students, young researchers
The Skolkovo Fund budget
17
19. Example. CSF of BMT Cluster
18
CSF
MAJOR
COLLABORATOR
PARTNERS
CO-INVESTOR, SUM OF
PROCEEDS IN 2011 FROM
CO-INVESTOR
SUM OF PROCEEDS
FROM SKOLKOVO
FOUNDATION IN
2011
Structural Biology.
Membrane protein and
their complexes
MIPT
- Institute of Structural Biology
(IBS, France)
- EMBL, Grenoble
- Research Centre (FZ-Juelich,
Germany)
- SCRIPPS Institute , (USA)
- ONEKSIM group
ONEXIM GROUP: 100 MM
RUB
MIPT: 160 MM RUB
200 MM RUB
Pre-clinical research.
GLP standards
IBC RAS
(Pushchino)
- Astra Zeneca
- RVC JSC
- ITEB RAS (Pushchino)
- Ministry of health, Russia
RVC JSC:150 MM RUB 150 MM RUB
Among the potential CSF of BMT Cluster “Center for Structural Biology of membrane proteins and
complexes“ and "Center of preclinical studies in the GLP standards” are the most elaborated
Strategic co-investors In two pilot CSF identified.
20. The need for CSF establishment
Implementation of development strategy
▪ Center for Shared Facilities (Center of Excellence) - a key element in implementation of the strategy
to create an innovative ecosystem by integrating services, education, research and innovation
(commercialization) functions.
▪ Effective use of the Fund assets in development of infrastructure
▪ Effective use of time until 2014 to educate and train own qualified staff on the own equipment
▪ CSF – qualified and high-liquid endowment of the future SIST
The reasons to start in 2011
▪ Implementation of the development strategy- 011, announced and approved by the Council. Effective use of
2011 year budget.
▪ The presence of a significant amount of infrastructural facilities (existing CSF, university laboratories and
research centers) that possess the required competencie. Many companies and institutional investors launch
a series of infrastructure projects. The optimal time to enter into alliances with major co-investors to create
CSF and CeO centers.
▪ Strong demand from Skolkovoparticipants
▪ The possibility of Russia Health Ministry participation
▪ A long lapse of time required for delivery and installation of laboratory equipment. The need to order
the equipment in the 1H 2011 In order to run it in the 4Q 2011.
19
21. BMT. System issues
20
The requirement to coordinate and enhance state support of the
The leading countries actively support the creation of large BMT CSF as the
organizer and the customer of innovations in the biomedicine and
biopharmaceuticals
Example – EMBL (European Molecular Biology Laboratories) - Europe's leading
interstate Centre for Molecular Biology and Biomedicine (includes 80 European
research institutes and independent research groups)
Proposals
To approve the concept to establish BMT CSF within the budget approved by
the Fund in March 2011
To use the experience and best practices of CSF establishment of world's
leading centers with help of Scientific Advisory Board.